MedCap AB (FRA:61MA) E10: €0.66 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:61MA MedCap AB FRA:61MA
91 GF Score
Price €45.54
GF Value €50.10
Valuation Fairly Valued
View Full Analysis

What is MedCap AB E10?

MedCap AB FRA:61MA -0.22% 91 E10 is €0.66 as of Mar. 2026. GuruFocus rates FRA:61MA with a GF Score™ of 91/100 and a GF Value™ of €50.10 (Fairly Valued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

MedCap AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.344. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.66 for the trailing ten years ended in Mar. 2026.

During the past 12 months, MedCap AB's average E10 Growth Rate was 22.90% per year. During the past 3 years, the average E10 Growth Rate was 29.90% per year. During the past 5 years, the average E10 Growth Rate was 33.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of MedCap AB was 37.80% per year. The lowest was 29.90% per year. And the median was 31.20% per year.

As of today (2026-07-17), MedCap AB's current stock price is €45.54. MedCap AB's E10 for the quarter that ended in Mar. 2026 was €0.66. MedCap AB's Shiller PE Ratio of today is 69.00.

During the past 13 years, the highest Shiller PE Ratio of MedCap AB was 148.93. The lowest was 58.94. And the median was 86.73.


MedCap AB  (FRA:61MA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

MedCap AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=45.54/0.66
=69.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of MedCap AB was 148.93. The lowest was 58.94. And the median was 86.73.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


MedCap AB E10 Related Terms


MedCap AB E10 Historical Data

* Premium members only.

The historical data trend for MedCap AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedCap AB E10 Chart

MedCap AB Annual Data
Trend Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.28 0.39 0.48 0.64

MedCap AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.57 0.59 0.64 0.66

FRA:61MA vs ABT, SYK, MDT: E10 Comparison

For the Medical Devices subindustry, MedCap AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedCap AB Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MedCap AB's Shiller PE Ratio falls into.


FRA:61MA
91GF Score
MedCap AB FRA:61MA
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedCap AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MedCap AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.344/133.5600*133.5600
=0.344

Current CPI (Mar. 2026) = 133.5600.

MedCap AB Quarterly Data

per share eps CPI Adj_EPS
201604 0.069 100.732 0.091
201607 0.011 101.080 0.015
201610 -0.010 101.485 -0.013
201701 -0.021 101.326 -0.028
201704 0.021 102.615 0.027
201707 0.031 103.301 0.040
201710 0.052 103.202 0.067
201803 0.059 103.962 0.076
201806 0.001 104.875 0.001
201809 0.010 105.679 0.013
201812 -0.068 105.912 -0.086
201903 0.114 105.886 0.144
201906 0.094 106.742 0.118
201909 0.075 107.214 0.093
201912 0.095 107.766 0.118
202003 0.064 106.563 0.080
202006 0.124 107.498 0.154
202009 0.077 107.635 0.096
202012 0.128 108.296 0.158
202103 0.088 108.360 0.108
202106 0.109 108.928 0.134
202109 0.177 110.338 0.214
202112 0.263 112.486 0.312
202203 0.123 114.825 0.143
202206 0.132 118.384 0.149
202209 0.231 122.296 0.252
202212 0.246 126.365 0.260
202303 0.152 127.042 0.160
202306 0.274 129.407 0.283
202309 0.220 130.224 0.226
202312 0.375 131.912 0.380
202403 0.336 132.205 0.339
202406 0.337 132.716 0.339
202409 0.308 132.304 0.311
202412 0.243 132.987 0.244
202503 0.310 132.825 0.312
202506 0.327 133.699 0.327
202509 0.309 133.480 0.309
202512 0.395 133.390 0.396
202603 0.344 133.560 0.344

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.66 mean?
MedCap AB (FRA:61MA) has a E10 of €0.66 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on MedCap AB and its competitors.
Is MedCap AB's E10 too high?
MedCap AB's current E10 is €0.66. Overall, MedCap AB has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MedCap AB's E10 compare to ABT and SYK?
MedCap AB's E10 of €0.66 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on MedCap AB and its competitors. MedCap AB's current E10 is €0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedCap AB stock overvalued right now?
Based on GuruFocus' analysis, MedCap AB (FRA:61MA) is currently considered Fairly Valued. The stock's GF Value™ is €50.10, compared to a current price of €45.54 — trading 9.1% below its estimated fair value. The current E10 is €0.66. MedCap AB's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For MedCap AB (FRA:61MA), the current E10 is €0.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MedCap AB (FRA:61MA) Overvalued in 2026?

Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued. The current stock price of €45.54 is trading 9.1% below its estimated GF Value™ of €50.10. GuruFocus considers MedCap AB to be Fairly Valued.

Key valuation signals for FRA:61MA:

  • E10: €0.66
  • GF Value™: €50.10 vs. price of €45.54 (9.1% below fair value)
  • GF Score™: 91/100

No single metric tells the full story. See the FRA:61MA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MedCap AB Business Description

Address Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
91GF Score

Get the complete analysis for FRA:61MA

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€45.54
Price
€50.10
GF Value